MCVT Among Core Aggregate ETFs
End-of-day Nov 17, 2026 · 82 Core aggregate ETFs by YTD
Bridgebio Pharma, Inc. 1.75%, Due 03/01/2031 3.6%Merit Medical Systems, Inc. 3%, Due 02/01/2029 3.1%Uber Technologies, Inc. 0.875%, Due 12/01/2028 3.0%Mirion Technologies, Inc. 0.25%, Due 06/01/2030 3.0%
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.9% | −3.2% | −2.4% | −8.7% | — | — | — | — | — | +4.4% |
| Peer average | +0.1% | −0.7% | +0.4% | −1.7% | −1.1% | −0.4% | +15.7% | +1.5% | +18.3% | — |
| S&P 500 · VOO | −1.0% | −2.4% | −4.5% | −4.5% | +8.3% | +10.2% | +72.7% | +68.0% | +305.1% | — |
$36 of every $1,000 in MCVT is Bridgebio
| # | |||||
|---|---|---|---|---|---|
| 1 | —Bridgebio Pharma, 1.75%, Due 03/01/2031 | 3.64% | $363.78 | 650K | $1.1M |
| 2 | —Merit Medical Systems, 3%, Due 02/01/2029 | 3.07% | $306.88 | 800K | $930K |
| 3 | —Uber Technologies, 0.875%, Due 12/01/2028 | 3.03% | $303.49 | 800K | $920K |
| 4 | —Mirion Technologies, 0.25%, Due 06/01/2030 | 3.01% | $300.54 | 900K | $911K |
| 5 | —Ormat Technologies, 2.5%, Due 07/15/2027 | 2.91% | $291.08 | 800K | $882K |
| 6 | —TransMedics Group, 1.5%, Due 06/01/2028 | 2.87% | $287.04 | 700K | $870K |
| 7 | —Etsy, 1%, Due 06/15/2030 | 2.82% | $282.32 | 700K | $856K |
| 8 | —Nova 0%, Due 09/15/2030 | 2.76% | $275.53 | 700K | $835K |
| 9 | —Dropbox, 0%, Due 03/01/2028 | 2.72% | $272.16 | 750K | $825K |
| 10 | —Granite Construction, 3.25%, Due 06/15/2030 | 2.72% | $271.74 | 500K | $824K |
| 11 | —Tetra Tech, 2.25%, Due 08/15/2028 | 2.66% | $265.61 | 700K | $805K |
| 12 | —Haemonetics 2.5%, Due 06/01/2029 | 2.65% | $264.61 | 650K | $802K |
| 13 | —HAT I, LLC / HAT II, LLC 3.75%, Due 08/15/2028 | 2.64% | $263.97 | 550K | $800K |
| 14 | —Bloom Energy 0%, Due 11/15/2030 | 2.62% | $261.94 | 650K | $794K |
| 15 | —Revolution Medicines, 0.5%, Due 05/01/2033 | 2.60% | $260.00 | 700K | $788K |
Not enough history yet: MCVT needs a year of prices.
Official documents are being connected from SEC EDGAR: […]. Read the issuer’s prospectus before investing.
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 15, 2026 | Sep 21, 2026 | $0.0236 |
| Jun 15, 2026 | Jun 22, 2026 | $0.0075 |
of the $591B in 91 Core aggregate ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | — | Bridgebio Pharma, 1.75%, Due 03/01/2031 | 3.64% |
| 2 | — | Merit Medical Systems, 3%, Due 02/01/2029 | 3.07% |
| 3 | — | Uber Technologies, 0.875%, Due 12/01/2028 | 3.03% |
| 4 | — | Mirion Technologies, 0.25%, Due 06/01/2030 | 3.01% |
| 5 | — | Ormat Technologies, 2.5%, Due 07/15/2027 | 2.91% |
| 6 | — | TransMedics Group, 1.5%, Due 06/01/2028 | 2.87% |
| 7 | — | Etsy, 1%, Due 06/15/2030 | 2.82% |
| 8 | — | Nova 0%, Due 09/15/2030 | 2.76% |
| 9 | — | Dropbox, 0%, Due 03/01/2028 | 2.72% |
| 10 | — | Granite Construction, 3.25%, Due 06/15/2030 | 2.72% |